# TMCI (Treace Medical Concepts, Inc.) - SEC EDGAR Financial Statements

> Treace Medical Concepts, Inc. reported $203.3M in revenue and a net loss of $55.79M for the trailing twelve months ended September 30, 2026 (down 3.9% year over year), with a 79.6% gross margin and a -24.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/TMCI
- Markdown: https://convexityos.com/fundamentals/TMCI.md
- SEC CIK: 0001630627
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001630627&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $203.3M | -3.9% YoY |
| Operating Income | TTM | -$49.58M | -24.4% margin |
| Net Income | TTM | -$55.79M | -27.4% net margin |
| Diluted EPS | TTM | -$0.85 | Split-adjusted |
| Free Cash Flow | TTM | -$18.57M | -9.1% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $39.80M | Total debt: $74.48M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $212.7M | $209.4M | $187.1M | $141.8M | $94.42M | $57.37M | $39.42M |
| Cost of Revenue | $42.94M | $41.09M | $35.18M | $25.53M | $16.89M | $12.47M | $7.63M |
| **Gross Profit** | $169.8M | $168.3M | $151.9M | $116.3M | $77.53M | $44.90M | $31.79M |
| Research & Development | $20.28M | $20.59M | $15.44M | $13.58M | $10.20M | $5.85M | $5.07M |
| Selling, General & Admin | $203.6M | $203.4M | $187.9M | $137.6M | $83.84M | $38.19M | $30.25M |
| Total Operating Expenses | $223.9M | $224.0M | $203.4M | $151.2M | $94.04M | $44.04M | $35.32M |
| **Operating Income** | -$54.15M | -$55.69M | -$51.43M | -$34.84M | -$16.51M | $855K | -$3.54M |
| **EBITDA** | -$43.53M | -$47.27M | -$46.08M | -$32.71M | -$15.82M | $2.06M | -$2.74M |
| Interest Expense | $5.32M | $5.26M | $5.17M | $4.40M | $4.06M | $2.78M | $841K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$59.00M | -$55.74M | -$49.53M | -$42.81M | -$20.55M | -$3.67M | -$4.26M |
| Basic EPS | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.43 | -$0.12 | -$0.13 |
| **Diluted EPS** | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.43 | -$0.12 | -$0.13 |
| Basic Shares Outstanding | 63.3M | 62.1M | 60.9M | 55.3M | 48.4M | 37.1M | 36.9M |
| Diluted Shares Outstanding | 63.3M | 62.1M | 60.9M | 55.3M | 48.4M | 37.1M | 36.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $48.25M | $45.38M | $47.20M | $62.52M | $50.21M | $47.39M | $52.57M | $68.71M |
| Cost of Revenue | $9.90M | $9.77M | $9.79M | $12.12M | $10.51M | $9.63M | $10.68M | $13.23M |
| **Gross Profit** | $38.35M | $35.61M | $37.41M | $50.40M | $39.71M | $37.75M | $41.89M | $55.48M |
| Research & Development | $4.49M | $4.38M | $4.62M | $4.54M | $4.68M | $5.50M | $5.56M | $5.21M |
| Selling, General & Admin | $45.39M | $46.19M | $49.95M | $51.78M | $50.70M | $49.23M | $51.91M | $50.47M |
| Total Operating Expenses | $49.88M | $50.56M | $54.57M | $56.32M | $55.38M | $54.73M | $57.48M | $55.68M |
| **Operating Income** | -$11.53M | -$14.96M | -$17.17M | -$5.92M | -$15.68M | -$16.97M | -$15.58M | -$204K |
| **EBITDA** | -$9.50M | -$13.07M | -$16.27M | -$3.11M | -$12.90M | -$14.40M | -$13.12M | $2.03M |
| Interest Expense | $1.58M | $1.56M | $1.57M | $1.35M | $1.34M | $1.32M | $1.31M | $1.31M |
| **Net Income** | -$12.57M | -$15.87M | -$17.96M | -$9.39M | -$16.29M | -$17.40M | -$15.92M | -$501K |
| Basic EPS | -$0.19 | -$0.24 | -$0.28 | -- | -$0.26 | -$0.28 | -$0.25 | -- |
| **Diluted EPS** | -$0.19 | -$0.24 | -$0.28 | -- | -$0.26 | -$0.28 | -$0.25 | -- |
| Basic Shares Outstanding | 65.5M | 65.0M | 64.6M | -- | 63.5M | 63.0M | 62.7M | -- |
| Diluted Shares Outstanding | 65.5M | 65.0M | 64.6M | -- | 63.5M | 63.0M | 62.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $10.71M | $11.35M | $12.98M | $19.47M | $105.8M | $18.08M |
| Short-Term Investments | $37.66M | $64.33M | $110.2M | $61.78M | $0 | -- |
| **Cash & Short-Term Investments** | $48.37M | $75.68M | $123.2M | $81.25M | $105.8M | $18.08M |
| Accounts Receivable, Net | $42.16M | $40.80M | $38.10M | $29.20M | $18.57M | $14.49M |
| Inventory | $36.03M | $39.26M | $29.25M | $19.33M | $10.56M | $7.82M |
| **Total Current Assets** | $132.1M | $161.4M | $198.4M | $133.4M | $138.0M | $40.98M |
| Property, Plant & Equipment, Net | $29.75M | $25.95M | $22.30M | $15.34M | $2.85M | $829K |
| Goodwill | $12.81M | $12.81M | $12.81M | $0 | -- | -- |
| Intangible Assets | $7.12M | $8.07M | $9.03M | $0 | -- | -- |
| Other Non-Current Assets | $1.22M | $407K | $146K | $146K | $0 | -- |
| **Total Non-Current Assets** | $58.53M | $55.69M | $53.55M | $25.62M | $2.85M | $829K |
| **Total Assets** | $190.6M | $217.1M | $251.9M | $159.0M | $140.8M | $41.81M |
| Accounts Payable | $6.73M | $10.52M | $11.84M | $8.67M | $4.06M | $2.27M |
| Short-Term Debt | $1.75M | $0 | -- | -- | -- | $1.79M |
| **Total Current Liabilities** | $30.64M | $34.92M | $45.03M | $30.25M | $18.21M | $11.60M |
| Long-Term Debt | $55.58M | $53.31M | $53.01M | $52.71M | $29.36M | $29.19M |
| Other Non-Current Liabilities | $3.05M | $37K | $37K | $0 | -- | -- |
| **Total Non-Current Liabilities** | $72.61M | $69.28M | $68.94M | $68.25M | $29.54M | $29.43M |
| **Total Liabilities** | $103.2M | $104.2M | $114.0M | $98.50M | $47.75M | $41.03M |
| **Total Debt (incl. Leases)** | $71.86M | $69.65M | $70.30M | $68.59M | $29.36M | $30.98M |
| Common Stock | $64K | $62K | $62K | $55K | $45K | -- |
| Retained Earnings | -$249.0M | -$190.0M | -$134.2M | -$84.72M | -$41.91M | -$21.35M |
| Accumulated Other Comp. Income | $72K | $97K | $163K | -$27K | $0 | -- |
| **Total Stockholders' Equity** | $87.33M | $112.9M | $137.9M | $60.53M | $93.07M | $776K |
| Total Equity | $87.33M | $112.9M | $137.9M | $60.53M | $93.07M | $776K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.76M | $12.61M | $9.54M | $10.71M | $7.69M | $8.05M | $13.37M | $11.35M |
| Short-Term Investments | $32.04M | $33.01M | $42.31M | $37.66M | $49.73M | $61.24M | $62.72M | $64.33M |
| **Cash & Short-Term Investments** | $39.80M | $45.62M | $51.85M | $48.37M | $57.42M | $69.29M | $76.09M | $75.68M |
| Accounts Receivable, Net | $30.22M | $28.73M | $30.36M | $42.16M | $32.96M | $30.33M | $31.11M | $40.80M |
| Inventory | $42.30M | $39.54M | $36.37M | $36.03M | $41.42M | $42.40M | $37.94M | $39.26M |
| **Total Current Assets** | $118.7M | $120.5M | $123.5M | $132.1M | $138.0M | $147.6M | $149.4M | $161.4M |
| Property, Plant & Equipment, Net | $33.04M | $32.50M | $32.06M | $29.75M | $29.97M | $29.71M | $27.13M | $25.95M |
| Goodwill | $12.81M | $12.81M | $12.81M | $12.81M | $12.81M | $12.81M | $12.81M | $12.81M |
| Intangible Assets | $6.41M | $6.65M | $6.89M | $7.12M | $7.36M | $7.60M | $7.84M | $8.07M |
| Other Non-Current Assets | $1.43M | $1.50M | $1.50M | $1.22M | $614K | $676K | $387K | $407K |
| **Total Non-Current Assets** | $60.61M | $60.60M | $60.63M | $58.53M | $58.59M | $58.84M | $56.41M | $55.69M |
| **Total Assets** | $179.3M | $181.1M | $184.1M | $190.6M | $196.6M | $206.4M | $205.8M | $217.1M |
| Accounts Payable | $14.28M | $16.06M | $13.54M | $6.73M | $16.10M | $19.96M | $13.22M | $10.52M |
| Short-Term Debt | $3.78M | $3.17M | $1.78M | $1.75M | $1.80M | $1.11M | $45K | $0 |
| **Total Current Liabilities** | $46.08M | $41.50M | $34.49M | $30.64M | $40.91M | $41.90M | $33.18M | $34.92M |
| Long-Term Debt | $56.26M | $56.04M | $55.82M | $55.58M | $53.53M | $53.45M | $53.38M | $53.31M |
| Other Non-Current Liabilities | $2.69M | $2.69M | $3.05M | $3.05M | $37K | $37K | $37K | $37K |
| **Total Non-Current Liabilities** | $71.58M | $71.82M | $72.42M | $72.61M | $66.50M | $66.93M | $67.33M | $69.28M |
| **Total Liabilities** | $117.7M | $113.3M | $106.9M | $103.2M | $107.4M | $108.8M | $100.5M | $104.2M |
| **Total Debt (incl. Leases)** | $74.48M | $72.69M | $71.60M | $71.86M | $70.37M | $70.09M | $69.36M | $69.65M |
| Common Stock | $66K | $65K | $65K | $64K | $64K | $63K | $63K | $62K |
| Retained Earnings | -$295.4M | -$282.8M | -$267.0M | -$249.0M | -$239.6M | -$223.3M | -$205.9M | -$190.0M |
| Accumulated Other Comp. Income | -$108K | -$52K | -$26K | $72K | $83K | $50K | $57K | $97K |
| **Total Stockholders' Equity** | $61.65M | $67.74M | $77.19M | $87.33M | $89.19M | $97.61M | $105.3M | $112.9M |
| Total Equity | $61.65M | $67.74M | $77.19M | $87.33M | $89.19M | $97.61M | $105.3M | $112.9M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$59.00M | -$55.74M | -$49.53M | -$42.81M | -$20.55M | -$3.67M | -$4.26M |
| Depreciation & Amortization | $10.62M | $8.42M | $5.35M | $2.13M | $685K | $1.21M | $793K |
| Stock-Based Compensation | $33.82M | $30.60M | $17.35M | $8.11M | $3.41M | $919K | $815K |
| Change in Receivables | -$2.09M | -$5.69M | -$9.30M | -$11.04M | -$4.23M | -$4.29M | -$6.02M |
| Change in Inventory | $3.22M | -$10.01M | -$9.85M | -$8.77M | -$2.74M | -$2.26M | -$2.81M |
| Change in Payables | -$3.80M | -$1.31M | $3.17M | $4.61M | $1.79M | $1.33M | -$236K |
| **Operating Cash Flow** | -$15.97M | -$37.17M | -$34.58M | -$30.65M | -$17.19M | -$4.49M | -$7.67M |
| Capital Expenditure | -$13.52M | -$11.59M | -$11.46M | -$14.84M | -$2.71M | -$1.07M | -$1.21M |
| **Free Cash Flow** | -$29.49M | -$48.76M | -$46.03M | -$45.49M | -$19.90M | -$5.56M | -$8.88M |
| Acquisitions, Net | $0 | $0 | -$20.00M | $0 | $0 | -- | -- |
| Purchases of Investments | -$40.57M | -$71.58M | -$169.9M | -$63.41M | $0 | $0 | -- |
| **Investing Cash Flow** | $13.25M | $35.38M | -$81.30M | -$76.52M | -$2.71M | -$1.07M | -$1.21M |
| **Financing Cash Flow** | $2.08M | $160K | $109.4M | $20.81M | $107.7M | $11.50M | $19.74M |
| **Net Change in Cash** | -$642K | -$1.63M | -$6.49M | -$86.36M | $87.75M | $5.94M | $10.86M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$12.57M | -$15.87M | -$17.96M | -$9.39M | -$16.29M | -$17.40M | -$15.92M | -$501K |
| Depreciation & Amortization | $2.03M | $1.89M | $899K | $2.81M | $2.78M | $2.58M | $2.46M | $2.24M |
| Stock-Based Compensation | $6.93M | $6.46M | $8.03M | $7.55M | $8.00M | $9.58M | $8.69M | $8.55M |
| Change in Receivables | -$1.61M | $1.50M | $11.69M | -$9.52M | -$2.56M | $696K | $9.29M | -$17.19M |
| Change in Inventory | -$2.76M | -$3.18M | -$335K | $5.39M | $973K | -$4.46M | $1.31M | $4.36M |
| Change in Payables | -$1.78M | $2.52M | $6.81M | -$9.38M | -$3.86M | $6.74M | $2.70M | -$8.13M |
| **Operating Cash Flow** | -$3.25M | -$4.70M | $7.24M | -$8.03M | -$9.09M | -$3.05M | $4.20M | -$4.21M |
| Capital Expenditure | -$2.17M | -$2.20M | -$3.06M | -$2.40M | -$2.81M | -$4.77M | -$3.54M | -$3.07M |
| **Free Cash Flow** | -$5.43M | -$6.90M | $4.18M | -$10.42M | -$11.90M | -$7.82M | $655K | -$7.28M |
| Purchases of Investments | -$7.51M | -$2.60M | -$16.07M | -$5.68M | -$4.64M | -$15.16M | -$15.09M | -$18.69M |
| **Investing Cash Flow** | -$1.26M | $7.07M | -$7.82M | $9.67M | $8.74M | -$3.26M | -$1.89M | $3.42M |
| **Financing Cash Flow** | -$335K | $696K | -$588K | $1.38M | -$10K | $987K | -$282K | $26K |
| **Net Change in Cash** | -$4.85M | $3.07M | -$1.16M | $3.02M | -$366K | -$5.32M | $2.02M | -$760K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 79.8% | 80.4% | 81.2% | 82.0% | 82.1% | 78.3% | 80.6% |
| **Operating Margin** | -25.5% | -26.6% | -27.5% | -24.6% | -17.5% | 1.5% | -9.0% |
| **Net Profit Margin** | -27.7% | -26.6% | -26.5% | -30.2% | -21.8% | -6.4% | -10.8% |
| Return on Equity (ROE) | -67.6% | -49.4% | -35.9% | -70.7% | -22.1% | -472.7% | -- |
| Return on Assets (ROA) | -31.0% | -25.7% | -19.7% | -26.9% | -14.6% | -8.8% | -- |
| Current Ratio | 4.31x | 4.62x | 4.40x | 4.41x | 7.58x | 3.53x | -- |
| Quick Ratio | 3.13x | 3.50x | 3.76x | 3.77x | 7.00x | 2.86x | -- |
| Debt to Equity | 0.82x | 0.62x | 0.51x | 1.13x | 0.32x | 39.92x | -- |
| **Revenue Growth (YoY)** | +1.6% | +11.9% | +31.9% | +50.2% | +64.6% | +45.5% | -- |
| Gross Profit Growth (YoY) | +0.9% | +10.7% | +30.6% | +50.0% | +72.7% | +41.2% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -2031.0% | -- | -- |
| 5Y Revenue / Share Growth | +117.2% | +215.6% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 79.6% | 79.5% | 79.7% | 79.8% | 79.9% | 80.1% | 80.2% | 80.4% |
| **Operating Margin** | -24.4% | -26.2% | -26.9% | -25.5% | -22.1% | -22.4% | -24.8% | -26.6% |
| **Net Profit Margin** | -27.4% | -29.0% | -29.4% | -27.7% | -22.9% | -23.0% | -25.1% | -26.6% |
| Return on Equity (ROE) | -90.5% | -87.9% | -79.1% | -67.6% | -56.2% | -50.4% | -50.3% | -49.4% |
| Return on Assets (ROA) | -31.1% | -32.9% | -33.2% | -31.0% | -25.5% | -23.8% | -25.7% | -25.7% |
| Current Ratio | 2.58x | 2.90x | 3.58x | 4.31x | 3.37x | 3.52x | 4.50x | 4.62x |
| Quick Ratio | 1.66x | 1.95x | 2.53x | 3.13x | 2.36x | 2.51x | 3.36x | 3.50x |
| Debt to Equity | 1.21x | 1.07x | 0.93x | 0.82x | 0.79x | 0.72x | 0.66x | 0.62x |
| **Revenue Growth (YoY)** | -3.9% | -4.2% | -10.2% | -9.0% | +11.4% | +6.6% | +2.9% | +10.4% |
| Gross Profit Growth (YoY) | -3.4% | -5.7% | -10.7% | -9.1% | +9.9% | +5.8% | +2.2% | +9.3% |
| Operating Cash Flow Growth (YoY) | -- | -- | +72.5% | -- | -- | -- | -- | -890.8% |
| Free Cash Flow Growth (YoY) | -- | -- | +537.9% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
